Market Cap | 448.69M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.93M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 41.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 42.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -19.00% |
Recommedations | - | Quick Ratio | 0.22 | Shares Outstanding | 25.64M | 52W Low Chg | 55.00% |
Insider Own | 2.61% | ROA | - | Shares Float | 21.12M | Beta | - |
Inst Own | 97.83% | ROE | - | Shares Shorted/Prior | 264.74K/517.38K | Price | 14.07 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 115,763 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 4,628,475 | Change | 48.26% |
Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.